Skip to main content

renal cancer

Research in Review
06/21/2016
JCP Editors
Surgery may improve survival for patients who receive targeted therapies for metastatic renal cell cancer, according to a study by researchers at Dana-Farber Cancer Institute and Brigham and Women’s Hospital (Boston,...
Surgery may improve survival for patients who receive targeted therapies for metastatic renal cell cancer, according to a study by researchers at Dana-Farber Cancer Institute and Brigham and Women’s Hospital (Boston,...
...
06/21/2016
Journal of Clinical Pathways
Research in Review
05/16/2016
JCP Editors
Patients with renal cell carcinoma may continue to benefit from treatment with nivolumab even after the disease has progressed, according a study published JAMA Oncology. Still a relatively new line of treatments,...
Patients with renal cell carcinoma may continue to benefit from treatment with nivolumab even after the disease has progressed, according a study published JAMA Oncology. Still a relatively new line of treatments,...
...
05/16/2016
Journal of Clinical Pathways
Research in Review
05/13/2016
JCP Editors
A look at 14 years of health care trends has revealed that the percentage of patients receiving treatment for metastatic renal cell carcinoma (mRCC) is growing as providers shift toward targeted therapeutic...
A look at 14 years of health care trends has revealed that the percentage of patients receiving treatment for metastatic renal cell carcinoma (mRCC) is growing as providers shift toward targeted therapeutic...
A look...
05/13/2016
Journal of Clinical Pathways